Biopharma startup Nocion nabs $27 mln Series A
Cambridge, Massachusetts-based Nocion Therapeutics, a biopharmaceutical startup, has raised $27 million in Series A funding. F-Prime Capital Partners and Canaan led the round with participation from Partners Innovation Fund and BioInnovation Capital.
18 April 2019•1 min read
